[1] Hallman M.The surfactant system protects both fetus and newborn[J].Neonatology,2013,103(4):320-326.
[2] Wert1 SE,Whitsett JA,Nogee LM.Genetic disorders of surfactant dysfunction[J].Pediatr Dev Pathol,2009,12(4):253-274.
[3] Gower WA,Wert SE,Nogee LM.Inherited surfactant disorders[J].NeoReviews,2008,9(10):e458-e467.
[4] Glasser SW,Witt TL,Senft AP,et al.Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection[J].Am J Physiol Lung Cell Mol Physiol,2009,297(1):64-72.
[5] Willander H,Askarieh G,Landreh M,et al.High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C[J].Proc Natl Acad Sci USA,2012,109(7):2325-2329.
[6] Mulugeta S,Maguire JA,Newitt JL,et al.Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms[J].Am J Physiol Lung Cell Mol Physiol,2007,293(3):L720-L729.
[7] Lawson WE,Crossno PF,Polosukhin VV,et al.Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF:association with altered surfactant protein processing and herpesvirus infection[J].Am J Physiol Lung Cell Mol Physiol,2008,294(6):L1119-L1126.
[8] Tobias T,Eva K,Suncana K,et al.SFTPC mutations cause SP-C degradation and aggregate formation without increasing ER stress[J].Eur J Clin Invest,2013,43(8):791-800.
[9] Garcia CK.Idiopathic pulmonary fibrosis:update on genetic discoveries[J].Proc Am Thorac Soc,2011,8(2):158-162.
[10] Nerelius C,Martin E,Peng S,et al.Mutations linked to interstitial lung disease can abrogate anit-amyloid function of prosurfactant C[J].Biochem J,2008,416(2):201-209.
[11] Glasser SW,Senft AP,Whitsett JA,et al.Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice[J].Immunolgy,2008,181(1):621-628.
[12] Van Moorsel CHM,Van Oosterhout MFM,Barlo NP,et al.Surfactant protein C mutations are the basis of a significant portion of adult pulmonary fibrosis in a Dutch Cohort[J].Am J Respir Crit Care Med,2010,182(11):1419-1425.
[13] Deutsch GH,Young LR,Deterding RR,et al.Diffuse lung disease in young children:application of a novel classification scheme[J].Am J Respir Crit Care Med,2007,176(11):1120-1128.
[14] Zarbock R,Woischnik M,Sparr C,et al.The surfactant protein C mutation A116D alters cellular processing,stress tolerance,surfactant lipid composition,and immune cell activation[J].BMC Pulmonary Medicine,2012,12:15-23.
[15] Pulkkinen V,Bruce S,Rintahaka J,et al.ELMOD2,a candidate gene for idiopathic pulmonary fibrosis,regulates antiviral responses[J].FASEB J,2010,24(4):1167-1177.
[16] Nerelius C,Martin E,Peng S,et al.Mutations linked to interstitial lung disease can abrogate anit-amyloid function of prosurfactant C[J].Biochem J,2008,416(2):201-209.
[17] Sipe JD,Benson MD,Buxbaum JN,et al.Amyloid fibril protein nomenclature:2010 recommendations from the nomenclature committee of the International Society of Amyloidosis[J].Amyloid,2010,17(3-4):101-104.
[18] Lomas NJ,Watts KL,Akram KM,et al.Idiopathic pulmonary fibrosis:immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers[J].Int J Clin Exp Pathol,2012,5(1):58-71.
[19] Schurch D,Ospina OL,Cruz A,et al.Combined and Independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films[J].Biophysical J,2010,99(12):3290-3299.
[20] Epaud R,Aubey F,Xu J,et al.Knockout of insulin-like growth factor-1 receptor impairs distal lung morphogenesis[J].PLoS One,2012,7(11):e48071.
[21] Schmeckebier S.Keratinocyte growth factor and dexametha-sone plus elevated c-AMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells[J].Tissue Eng Part A,2013,19(7-8):938-951 |
